Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
R&D Progress: Enrollment of Subjects in Phase III Clinical Trial for Inhaled Aerosol Drug in Children by Kexing Biopharm 2024-04-10 11:41
Alphamab Oncology Presented the Dose-escalation Results from JSKN003 in Patients with Advanced/Metastatic Solid Tumors at AACR 2024-04-10 08:40
The Second International Conference on Single-cell and Spatial Omics (TICSSO-2) : showcasing the state-of-the-art bioscience achievements 2024-04-09 23:14
BioCity Announces FDA Clearance of the Investigational New Drug Application for its First-In-Class Antibody Drug Conjugate Targeting Glypican 3 2024-04-09 22:10
YS Biopharma Announces Positive Interim Results of Pivotal Phase 3 Clinical Study of PIKA Rabies Vaccine 2024-04-09 20:00
Jacobio Pharma to Present Data of PARP7 Inhibitor and P53 Reactivator at the 2024 AACR Annual Meeting 2024-04-09 19:59
GenFleet Therapeutics Announces Broad-spectrum Activity of GFH547, an Oral panRAS (ON) Inhibitor, and Its Potential to Overcome Resistance against SIIP-based KRAS Inhibitors in Late-breaking Research Abstract of 2024 AACR Annual Meeting 2024-04-09 19:00
Fiscal Year 2023: Exyte experiences strong growth in Europe and the USA 2024-04-09 17:52
Waters Launches Alliance iS Bio HPLC System to Help Biopharma QC Labs Increase Efficiency and Reduce Errors 2024-04-09 14:00
Transcenta Announces Collaboration with Agilent to Develop a Claudin18.2 Companion Diagnostic to Support Osemitamab (TST001) Global Phase III Trial 2024-04-09 09:18
Abbisko Completed All Patient Enrollment for The Global Phase III TGCT Trial of Its CSF-1R Inhibitor - Pimicotinib 2024-04-09 08:30
MAIWEIJIAN, First Approved Biosimilar of Denosumab (120mg) in China 2024-04-08 22:00
Seegene and UK Health Security Agency convene a summit to collectively realize "a World Free from All Diseases" 2024-04-08 20:00
SeekIn Presents New OncoSeek® Data at the AACR Annual Meeting in San Diego 2024-04-08 20:00
Clover Announces Positive Preliminary Phase I Results for Bivalent RSV Vaccine Candidate SCB-1019 in Initial Young Adult Cohort 2024-04-08 17:19
D3 Bio Completes Series A+ Round to Advance Innovative Oncology Pipeline 2024-04-08 15:00
Patient Enrolment Completed in CYP-006TK Diabetic Foot Ulcer Clinical Trial 2024-04-08 08:47
Innovent to Present Preclinical Data of Multiple Novel Molecules at the 2024 AACR Annual Meeting 2024-04-08 08:00
AACR 2024 | Ascentage Pharma Presents Results from Three Studies at 2024 American Association of Cancer Research Annual Meeting 2024-04-08 07:58
Antengene Presents Four Preclinical Posters at AACR 2024 2024-04-06 08:30
1 42 43 44 45 46 451